A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Philomena Colucci
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Addenbrookes Hospital
Cambridge, United Kingdom
- Beatson West of Scotland Cancer Centrewester
Glasgow, United Kingdom
- Guys Hospital
London, United Kingdom
- St Bartholomew'S Hospital
London, United Kingdom
- the Royal Marsden
London, United Kingdom
- the Royal Marsden Nhs Foundation Trust - Sutton
Sutton, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Apr 2024
- Primary completion
- 6 Jun 2025
- Completion
- 6 Jun 2025
- Last update posted
- 4 Jun 2026
- Registered enrollment
- 5
- Registry id
- NCT05949632
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.